The ACME Laboratories Statistics

Total Valuation

The ACME Laboratories has a market cap or net worth of BDT 16.80 billion. The enterprise value is 37.24 billion.

Market Cap	16.80B
Enterprise Value	37.24B

Important Dates

The next estimated earnings date is Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	Nov 21, 2024

Share Statistics

The ACME Laboratories has 211.60 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	211.60M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	37.64%
Owned by Institutions (%)	3.98%
Float	131.95M

Valuation Ratios

The trailing PE ratio is 7.15.

PE Ratio	7.15
Forward PE	n/a
PS Ratio	0.52
PB Ratio	0.66
P/TBV Ratio	0.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.11, with an EV/FCF ratio of -30.22.

EV / Earnings	15.84
EV / Sales	1.15
EV / EBITDA	5.11
EV / EBIT	6.58
EV / FCF	-30.22

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.91.

Current Ratio	1.12
Quick Ratio	0.29
Debt / Equity	0.91
Debt / EBITDA	3.20
Debt / FCF	-18.90
Interest Coverage	2.30

Financial Efficiency

Return on equity (ROE) is 9.48% and return on invested capital (ROIC) is 7.48%.

Return on Equity (ROE)	9.48%
Return on Assets (ROA)	6.54%
Return on Capital (ROIC)	7.48%
Revenue Per Employee	3.48M
Profits Per Employee	252,707
Employee Count	9,301
Asset Turnover	0.60
Inventory Turnover	1.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.59% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-6.59%
50-Day Moving Average	76.37
200-Day Moving Average	75.88
Relative Strength Index (RSI)	62.80
Average Volume (20 Days)	598,504

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, The ACME Laboratories had revenue of BDT 32.35 billion and earned 2.35 billion in profits. Earnings per share was 11.11.

Revenue	32.35B
Gross Profit	13.45B
Operating Income	5.66B
Pretax Income	3.10B
Net Income	2.35B
EBITDA	7.25B
EBIT	5.66B
Earnings Per Share (EPS)	11.11

Full Income Statement

Balance Sheet

The company has 2.85 billion in cash and 23.29 billion in debt, giving a net cash position of -20.44 billion or -96.60 per share.

Cash & Cash Equivalents	2.85B
Total Debt	23.29B
Net Cash	-20.44B
Net Cash Per Share	-96.60
Equity (Book Value)	25.61B
Book Value Per Share	121.02
Working Capital	2.54B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.70 billion and capital expenditures -3.93 billion, giving a free cash flow of -1.23 billion.

Operating Cash Flow	2.70B
Capital Expenditures	-3.93B
Free Cash Flow	-1.23B
FCF Per Share	-5.82

Full Cash Flow Statement

Margins

Gross margin is 41.57%, with operating and profit margins of 17.51% and 7.27%.

Gross Margin	41.57%
Operating Margin	17.51%
Pretax Margin	9.57%
Profit Margin	7.27%
EBITDA Margin	22.42%
EBIT Margin	17.51%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 4.41%.

Dividend Per Share	3.50
Dividend Yield	4.41%
Dividend Growth (YoY)	6.06%
Years of Dividend Growth	2
Payout Ratio	29.72%
Buyback Yield	n/a
Shareholder Yield	4.41%
Earnings Yield	13.99%
FCF Yield	-7.33%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

The ACME Laboratories has an Altman Z-Score of 1.64. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.64
Piotroski F-Score	n/a